Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Other Long-Term Liabilities : ¥6,689 Mil (As of Mar. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities?

Shanghai Fosun Pharmaceutical (Group) Co's other long-term liabilities for the quarter that ended in Mar. 2025 was ¥6,689 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly other long-term liabilities declined from Sep. 2024 (¥6,675 Mil) to Dec. 2024 (¥6,327 Mil) but then increased from Dec. 2024 (¥6,327 Mil) to Mar. 2025 (¥6,689 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual other long-term liabilities increased from Dec. 2022 (¥6,532 Mil) to Dec. 2023 (¥6,892 Mil) but then declined from Dec. 2023 (¥6,892 Mil) to Dec. 2024 (¥6,327 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

3,456.91

5,610.63

6,532.18

6,892.01

6,327.16

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															6,836.35	6,786.91	6,675.20	6,327.16	6,688.62

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

SFOSF:USA 02196:Hong Kong 08HH:Germany 08HH:Germany

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Executives

Yao Fang	Director
Wu Yi Fang	Director
Wen De Yong	Directors, senior managers
Guan Xiao Hui	Director
Wang Ke Xin	Director
Bao Qin Gui	senior management
Mei Jing Ping	senior management
Li Sheng Li	senior management
Feng Rong Li	senior management
Wang Dong Hua	senior management
Dong Xiao Xian	senior management
Su Li	senior management
Zhu Yue	senior management
Chen Yu Qing	senior management
Hu Hang	senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines